Hayley Brown, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 10001 S Eastern Ave, Henderson, NV 89052 Phone: 702-260-7707 Fax: 702-990-1972 |
Dr. John Joseph Minoli, M.D., F.A.C.S. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 870 Seven Hills Dr, Suite 101, Henderson, NV 89052 Phone: 702-459-3223 Fax: 702-260-0275 |
Samuel Myungjin Sohn, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 60 N Pecos Rd, Henderson, NV 89074 Phone: 702-897-1330 Fax: 702-897-9499 |
Dr. Christopher Khorsandi, MD Plastic Surgery - Surgery of the Hand Medicare: Not Enrolled in Medicare Practice Location: 2779 Sunridge Heights Pkwy, Ste 100, Henderson, NV 89052 Phone: 702-608-1318 Fax: 702-446-8026 |
Dr. Himansu R Shah, M.D. Plastic Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 3035 W Horizon Ridge Pkwy, Suite 100, Henderson, NV 89052 Phone: 702-684-5502 Fax: 702-684-5503 |
Arthur M. Cambeiro, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2370 W Horizon Ridge Pkwy, Ste 130, Henderson, NV 89052 Phone: 702-566-8300 |
Jeffrey B. Horton, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2200 Twin Falls Dr, Henderson, NV 89044 Phone: 214-766-0041 |
News Archive
Doctors should wait for more evidence before signing on to the notion that the sudden development of symptoms like tics or behavioral problems in a child is related to a strep infection, according to researchers writing in the April issue of the journal Pediatrics.
Performing tonsillectomy before radiotherapy in patients with stage I/II tonsil cancer is associated with improved survival, an analysis of US data indicates.
Three leading Canadian language and speech experts will take centre stage in discussions on the latest developments in speech research at this year's annual meeting of the American Association for the Advancement of Science in Washington, D.C.
Every day, more than 15 million unpaid caregivers provide care to people with Alzheimer's disease, with little outside support and often at the risk of their own health.
Æterna Zentaris Inc. (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, today announced that on January 21, 2010, the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market indicating that the minimum closing bid price of its common shares had fallen below US$1.00 for 30 consecutive trading days, and therefore, Æterna Zentaris was not in compliance with NASDAQ Listing Rule 5450(a)(1) (the "Rule").
› Verified 1 days ago